Cas:467451-81-6 2-(6-(Trifluoromethoxy)-1H-indol-3-yl)ethanamine hydrochloride manufacturer & supplier

We serve Chemical Name:2-(6-(Trifluoromethoxy)-1H-indol-3-yl)ethanamine hydrochloride CAS:467451-81-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(6-(Trifluoromethoxy)-1H-indol-3-yl)ethanamine hydrochloride

Chemical Name:2-(6-(Trifluoromethoxy)-1H-indol-3-yl)ethanamine hydrochloride
CAS.NO:467451-81-6
Synonyms:2-[6-(Trifluoromethoxy)-1H-indol-3-yl]ethanamine;1H-Indole-3-ethanamine, 6-(trifluoromethoxy)-
Molecular Formula:C11H11F3N2O
Molecular Weight:244.213
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:335.6±37.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.571
PSA:51.04000
Exact Mass:244.082352
LogP:2.27

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-[6-(Trifluoromethoxy)-1H-indol-3-yl]ethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Indole-3-ethanamine, 6-(trifluoromethoxy)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Indole-3-ethanamine, 6-(trifluoromethoxy)- Use and application,2-[6-(Trifluoromethoxy)-1H-indol-3-yl]ethanamine technical grade,usp/ep/jp grade.


Related News: ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. 2-(6-(Trifluoromethoxy)-1H-indol-3-yl)ethanamine hydrochloride manufacturer If the Justice Department concludes that an internal investigation was thorough, it can result in a non-prosecution agreement with few, if any, penalties, the experts said. However, a company-led investigation that appears to have been poorly handled could lead to harsher outcomes. 2-(6-(Trifluoromethoxy)-1H-indol-3-yl)ethanamine hydrochloride supplier When they do design their phase 3, they’re going to need to be better about that part of the study design, and really focus on enrolling individuals that have the right biomarkers to be able to look at not only the safety and tolerability but also the efficacy on cognition and function,” Edelmayer said.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau. 2-(6-(Trifluoromethoxy)-1H-indol-3-yl)ethanamine hydrochloride vendor ��Once these risks have been identified then a project team can be put together combining the necessary expertise to provide the integrated services and tailored support to ensure continuity of supply from beginning to end.�� 2-(6-(Trifluoromethoxy)-1H-indol-3-yl)ethanamine hydrochloride factory If the Justice Department concludes that an internal investigation was thorough, it can result in a non-prosecution agreement with few, if any, penalties, the experts said. However, a company-led investigation that appears to have been poorly handled could lead to harsher outcomes.